Related Experiment Video
Updated: Jul 17, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery
Eli I Lev1, Mahesh Ramchandani, Rajeev Garg
1Department of Cardiology, The Methodist Hospital Research Institute, The Methodist DeBakey Heart Center, Houston, TX 77030, USA.
Insights
Low response to aspirin is linked to poor clopidogrel response in patients undergoing cardiovascular surgery. This suggests a potential need for personalized antiplatelet therapy in this group.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Previous studies linked low platelet response to aspirin with clopidogrel non-response in percutaneous coronary intervention patients.
- The relationship between aspirin and clopidogrel response in patients undergoing major cardiovascular surgery remained unclear.
Purpose of the Study:
- To investigate the association between aspirin and clopidogrel response in patients scheduled for cardiac or vascular surgery.
- To determine if low response to one antiplatelet agent predicts low response to the other in this surgical cohort.
Main Methods:
- 100 patients scheduled for cardiac/vascular surgery on aspirin and clopidogrel were analyzed.
- Platelet function was assessed using the modified TEG platelet mapping assay (ADP, AA) and PFA-100 assay (CEPI, CADP).
- Low response was defined as < or =20% inhibition for TEG-ADP or TEG-AA.
Main Results:
- 13% of patients were low responders to aspirin and 34% to clopidogrel.
- Eight patients exhibited low response to both aspirin and clopidogrel.
- Aspirin low responders showed significantly lower TEG-ADP inhibition (P=0.03) and a trend towards lower PFA-CADP time (P=0.1).
- Clopidogrel low responders demonstrated significantly lower TEG-AA inhibition (P=0.01) and a trend towards lower PFA-CEPI time (P=0.07).
Conclusions:
- Low response to aspirin is significantly associated with low response to clopidogrel in patients undergoing cardiovascular surgery.
- These findings highlight a potential link between antiplatelet drug response across different agents in surgical patients.
- Further research may explore implications for perioperative antiplatelet management.
Background:
Recent data indicate that among patients undergoing percutaneous coronary intervention low platelet response to aspirin is associated with clopidogrel low response. It is unclear whether these findings extend to other patient populations. We, therefore, aimed to evaluate the relation between response to aspirin and clopidogrel among patients scheduled to undergo cardiac or vascular surgery.
Methods:
Patients who were scheduled for cardiac or vascular surgery and had taken aspirin 81-325 mg daily for at least a week and clopidogrel 75 mg daily for at least 3 days underwent blood testing for platelet function. One hundred patients were included in the current analysis. Platelet function was evaluated by the modified TEG platelet mapping assay with addition of ADP or arachidonic acid (AA), and by the PFA-100 assay with collagen-epinephrine (CEPI) or collagen-ADP (CADP) cartridges. Low response to aspirin or clopidogrel was defined as inhibition < or =20% for TEG-AA or TEG-ADP, respectively.
Results:
Thirteen patients (13%) were low responders to aspirin and 34 (34%) were low responders to clopidogrel. Eight patients were low responders to both drugs. There were no differences in clinical characteristics between drug low responders versus sensitive patients. Aspirin low responders had lower TEG-ADP inhibition (19.5 +/- 6 vs. 35.8 +/- 3%, P = 0.03) and tended to have lower PFA-CADP time (84.7 +/- 7 vs. 105.6 +/- 5 s, P = 0.1) than aspirin sensitive patients. Clopidogrel low responders had lower TEG-AA inhibition (58 +/- 6 vs. 75.1 +/- 4%, P = 0.01) and PFA-CEPI time (168 +/- 13 vs. 200.4 +/- 10 s, P = 0.07) than clopidogrel sensitive patients.
Conclusions:
In patients scheduled to undergo cardiovascular surgery low response to aspirin is associated with low response to clopidogrel.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiomyopathy VII: Pre and Post Operative Nursing Management